Skip to main content

Peer Review reports

From: Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response

Original Submission
23 Nov 2022 Submitted Original manuscript
27 Dec 2022 Author responded Author comments - Hai sheng Wang
7 Jan 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 2
27 Dec 2022 Submitted Manuscript version 2
17 Jan 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 3
17 Jan 2023 Submitted Manuscript version 3
18 Jan 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 4
18 Jan 2023 Submitted Manuscript version 4
19 Jan 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 5
19 Jan 2023 Submitted Manuscript version 5
21 Feb 2023 Reviewed Reviewer Report - Shuqiao Zhang
24 Mar 2023 Reviewed Reviewer Report
4 Apr 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 6
4 Apr 2023 Submitted Manuscript version 6
6 Apr 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 7
6 Apr 2023 Submitted Manuscript version 7
9 Apr 2023 Reviewed Reviewer Report - Shuqiao Zhang
9 Apr 2023 Reviewed Reviewer Report
19 Apr 2023 Author responded Author comments - Hai sheng Wang
Resubmission - Version 8
19 Apr 2023 Submitted Manuscript version 8
Publishing
25 Apr 2023 Editorially accepted
18 May 2023 Article published 10.1186/s12906-023-03975-0

You can find further information about peer review here.

Back to article page